Abstracts tagged "Imaging"

Abstract Number: 2889 • 2013 ACR/ARHP Annual Meeting
Bone Marrow Edema and Structural Lesions In The Sacroiliac Joint In a Large Cohort Of Patients With Axial Spondyloarthritis, Chronic Low Back Pain and Healthy Controls
L. van Hoeven^1,2, J.J. Luime², P.D.M. de Buck³, J.M.W. Hazes² and A.E.a.M. Weel⁴, ¹Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, ²Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, ³Rheumatology, MC Haaglanden, Den Haag, Netherlands, ⁴Department of Rheumatology, Maasstad Hospital, Rotterdam, Netherlands
Background/Purpose: MRI of the sacroiliac joint (SIJ) is included in the ASAS classification criteria for axial spondyloarthritis (axSpA) to identify patients at an earlier stage of…
Abstract Number: 863 • 2013 ACR/ARHP Annual Meeting
Romosozumab Administration Is Associated With Significant Improvements In Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared With Teriparatide
H K Genant¹, S Boonen², M A Bolognese³, C Mautalen⁴, J P Brown⁵, C Recknor⁶, S Goemaere⁷, K Engelke⁸, Y-C Yang⁹, M Austin⁹, A Grauer⁹ and C Libanati⁹, ¹UCSF & Synarc Inc., San Francisco, CA, ²Leuven University Division of Geriatric Medicine, Leuven, Belgium, ³The Bethesda Health Research Center, Bethesda, MD, ⁴Centro de Osteopatias Medicas, Buenos Aires, Argentina, ⁵CHU de Québec Research Centre and Laval University, Québec, QC, Canada, ⁶United Osteoporosis Centers, Gainesville, GA, ⁷Ghent University Hospital, Ghent, Belgium, ⁸Synarc Germany, Hamburg, Germany, ⁹Amgen Inc., Thousand Oaks, CA
Background/Purpose: Sclerostin is an osteocyte-derived inhibitor of osteoblast activity. Romosozumab, a monoclonal antibody to sclerostin stimulates bone formation and decreases bone resorption. In a phase…
Abstract Number: 2820 • 2013 ACR/ARHP Annual Meeting
Disease-Regulated Local Interleukin-10 Gene Therapy Diminishes Synovitis and Articular Cartilage Damage In Experimental Arthritis
Eline A. Vermeij¹, Mathijs G.A. Broeren¹, Miranda B. Bennink¹, Onno J. Arntz², Inger Gjertsson³, Wim B. van den Berg¹ and Fons A.J. van de Loo¹, ¹Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ³Department of Rheumatology and Inflammation Research, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden
Background/Purpose: Rheumatoid arthritis (RA) is a chronic destructive autoimmune disease and in most patients the disease follows an intermittent course with periods of exacerbation and…
Abstract Number: 615 • 2013 ACR/ARHP Annual Meeting
Relationship Between 25-Hydroxyvitamin D [25(OH)D] and Risk For Cardiovascular Events In Systemic Lupus Erythematosus Over 11 Years In An Inception Cohort
Apinya Lertratanakul¹, Peggy Wu², Alan Dyer¹, Dafna D. Gladman³, Murray B. Urowitz³, Paul R. Fortin⁴, Dominique Ibanez³, Rosalind Ramsey-Goldman⁵ and for the Systemic Lupus International Collaborating Clinics (SLICC)⁶, ¹Northwestern University, Chicago, IL, ²Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada, ⁵Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Toronto Western Hospital, Division of Rheumatology, University of Toronto, Toronto Western Hospital (Coordinating Center), Toronto, ON, Canada
Background/Purpose: 25(OH)D deficiency has been associated with increased cardiovascular disease (CVD) in the general population. We investigated the relationship between 25(OH)D and CVD events in…
Abstract Number: 2801 • 2013 ACR/ARHP Annual Meeting
Comparative Longitudinal Analysis Of Periarticular Bone Structure In Patients Treated With Methotrexate In Combination Of Either TNF Blockers Or Tocilizumab
Sebastian Kraus¹, Matthias Englbrecht¹, Juergen Rech², Roland Kocijan¹, Georg A. Schett¹ and Stephanie Finzel¹, ¹Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: Inhibition of tumor necrosis factor alpha (TNFi) and interleukin-6 receptor (IL6Ri, tocilzumab) are among the most potent therapeutic strategies in patients with rheumatoid arthritis…
Abstract Number: 307 • 2013 ACR/ARHP Annual Meeting
Abnormal Imaging and Increased Osteoclast Precursors In a Psoriasis Cohort Are Associated with New Onset of Psoriatic Arthritis
Ralf G. Thiele¹, Yahui Grace Chiu¹, Francisco A. Tausk², Bethany A. Marston¹, Gregory Dieudonne³, Vaseem Chengazi³, Michelle Smith¹, Sharon Moorehead¹, Rick Barrett¹ and Christopher T. Ritchlin¹, ¹Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, ²Dermatology, University of Rochester, Rochester, NY, ³Radiology, University of Rochester, Rochester, NY
Background/Purpose: Psoriasis (Ps) precedes joint inflammation by about 10 years in patients who develop psoriatic arthritis (PsA). Several studies have documented abnormal musculoskeletal imaging findings…
Abstract Number: 2604 • 2013 ACR/ARHP Annual Meeting
Longitudinal Assessment Of Scleroderma Skin By Optical Coherence Tomography: Preliminary Validation Of Sensitivity To Change Over-Time
Giuseppina Abignano¹, Lesley-Anne Bissell¹, Jason Britton², Daniel Woods³, Maya H. Buch¹, Dennis McGonagle¹, Paul Emery¹ and Francesco Del Galdo¹, ¹Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ²Medical Physics Department, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ³Michelson Diagnostics Ltd, Kent, United Kingdom
Background/Purpose: Optical coherence tomography (OCT) has been shown to be a quantitative reliable tool to assess skin involvement in Systemic Sclerosis (SSc) (1). However the…
Abstract Number: 240 • 2013 ACR/ARHP Annual Meeting
Longitudinal Femorotibial Cartilage Thickness Increase In Young Athletes At The End Of Adolescence
Felix Eckstein¹, Heide Boeth², Gerd Diederichs³, Wolfgang Wirth¹, Martin Hudelmaier⁴, Sebastian Cotofana⁵ and Georg Duda⁶, ¹Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, ²Center for Sports Science and Sports Medicine, Julius Wolff Institute, Charité – Universitätsmedizin Berlin, Berlin, Germany, ³Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany, ⁴Paracelsus Medical University, Salzburg, Austria, ⁵Musculoskeletal Anatomy, Paracelsus Medical University, Salzburg, Austria, ⁶Julius Wolff Institute, Charité – Universitätsmedizin Berlin, Berlin, Germany
Background/Purpose: Anterior or posterior cruciate ligament (ACL/PCL) ruptures are thought to lead to early knee osteoarthritis (KOA) and thus considered scientifically valuable “models” of pre-radiographic…
Abstract Number: 1969 • 2013 ACR/ARHP Annual Meeting
Ankle Joint Involvement In Rheumatoid Arthritis. An Ultrasound Study Using High Resolution- and Colour Doppler Ultrasound
Mohammed Alsuwaidi¹, Boris P. Ehrenstein¹, Martin Fleck² and Wolfgang Hartung¹, ¹Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, ²Internal Medicine I, University Medical Center of Regensburg, Regensburg, Germany
Background/Purpose: Despite a pivotal role for RA patients mobility, the ankle joints are frequently neglected, and omitted in activity scoring systems including DAS 28. In…
Abstract Number: 231 • 2013 ACR/ARHP Annual Meeting
Variable Imaging Characteristics Identified By Point-Of-Care Ultrasound For Greater Trochanteric Pain Syndrome
Minna J. Kohler¹, Naina Rastalsky² and Liana Fraenkel³, ¹Rheumatology, Allergy, and Immunology, Massachusetts General Hospital / Harvard Medical School, Boston, MA, ²Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ³Medicine, Section of Rheumatology, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, New Haven, CT
Background/Purpose: Greater trochanteric pain syndrome (GTPS) is a common cause of musculoskeletal pain that has been typically attributed to trochanteric bursitis. It encompasses a spectrum…
Abstract Number: 1973 • 2013 ACR/ARHP Annual Meeting
Importance Of Hand Positioning In 3D Joint Space Morphology Assessment
Stephanie Boutroy¹, Elodie Hirschenhahn¹, Emile Youssof², Hervé Locrelle², Thierry Thomas², Roland Chapurlat³ and Hubert Marotte², ¹INSERM U1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, ²INSERM U1059 and University Hospital, Hôpital Nord, Saint-Etienne, France, ³INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France
Background/Purpose: Precise quantification of joint space morphology (JSM) is an important factor for early diagnosis and monitoring of disease activity and therapeutic responses in rheumatoid…
Abstract Number: 216 • 2013 ACR/ARHP Annual Meeting
Systematic Staging For Uric Acid Deposits With Dual-Energy Computed Tomography and Ultrasound In Suspected Gout
Wolfgang A. Schmidt¹ and Alexander Huppertz², ¹Med Ctr Rheumatology Berlin Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, ²Imaging Science Institute Charité, Berlin, Germany
Background/Purpose: To evaluate the diagnostic accuracy of Dual-Energy Computed Tomography (DECT) and ultrasound for detecting monosodium urate crystal deposits in patients with clinically suspected gout.…
Abstract Number: 1959 • 2013 ACR/ARHP Annual Meeting
Extremity MRI Scans of the Hand and the Diagnosis of Inflammatory Arthritis: Findings in Patients With a Clinical Diagnosis of RA, Non-Inflammatory Arthritis and Fibromyalgia
Robert S. Katz¹, Hannah Bond² and Anthony Farkasch², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Low field extremity MRI has been utilized to evaluate patients for inflammatory arthritis and to follow their progress on immunosuppressive and biologic therapy. …

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.